{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:36:57Z","timestamp":1772249817579,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Stiftelsen Konung Gustaf V:s 80-\u00e5rsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00613","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T01:39:18Z","timestamp":1588729158000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-Inflammatory Properties of Chemical Probes in Human Whole Blood: Focus on Prostaglandin E2 Production"],"prefix":"10.3389","volume":"11","author":[{"given":"Filip","family":"Bergqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Mei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"B1","first-page":"862","article-title":"Prostaglandin E 2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro","volume":"23","author":"Agro","year":"1996","journal-title":"J. Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/187153006779025711","article-title":"Role of PGE2 and EP Receptors in the Pathogenesis of Rheumatoid Arthritis and as a Novel Therapeutic Strategy","volume":"6","author":"Akaogi","year":"2012","journal-title":"Endocrine Metab. Immune Disord. - Drug Targets"},{"key":"B3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2017.08.004","article-title":"Interleukin-8 in cancer pathogenesis, treatment and follow-up","volume":"60","author":"Alfaro","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nchembio.1867","article-title":"The promise and peril of chemical probes","volume":"11","author":"Arrowsmith","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1152\/ajplung.00248.2011","article-title":"Prostaglandin e 2 enhances interleukin-8 production via ep4 receptor in human pulmonary microvascular endothelial cells","volume":"302","author":"Aso","year":"2012","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1101\/2019.12.30.890715","article-title":"Anti-inflammatory properties of chemical probes in human whole blood: focus on prostaglandin E2 production","volume-title":"bioRxiv","author":"Bergqvist","year":"2019"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106383","article-title":"A review on mPGES-1 inhibitors: From preclinical studies to clinical applications","volume":"147","author":"Bergqvist","year":"2020","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri3362","article-title":"The resolution of inflammation","volume":"13","author":"Buckley","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1194\/jlr.R800033-JLR200","article-title":"Phospholipase A 2 structure\/function, mechanism, and signaling","volume":"50","author":"Burke","year":"2009","journal-title":"J. Lipid Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1074\/jbc.M410725200","article-title":"Prostaglandin E2 induces interleukin-8 gene transcription by activating C\/EBP homologous protein in human T lymphocytes","volume":"280","author":"Caristi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines4030022","article-title":"The IL-8\/IL-8R axis: A double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines"},{"key":"B12","first-page":"887","article-title":"Lysophosphatidylcholine and lysophosphatidylinosiol novel promissing signaling molecules and their possible therapeutic activity","volume":"71","author":"Drzazga","year":"2014","journal-title":"Acta Poloniae Pharm. - Drug Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/239310","article-title":"Prostaglandins and Rheumatoid Arthritis","volume":"2012","author":"Fattahi","year":"2012","journal-title":"Arthritis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/labinvest.2016.140","article-title":"Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells","volume":"97","author":"Hartman","year":"2017","journal-title":"Lab. Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrrheum.2011.132","article-title":"Neutrophils in the pathogenesis and manifestations of SLE","volume":"7","author":"Kaplan","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4049\/jimmunol.1301906","article-title":"IL-6\u2013Mediated Induction of Matrix Metalloproteinase-9 Is Modulated by JAK-Dependent IL-10 Expression in Macrophages","volume":"192","author":"Kothari","year":"2014","journal-title":"J. Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1111\/bph.14827","article-title":"Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone","volume":"176","author":"Larsson","year":"2019","journal-title":"Br. J. Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/ard.2005.038315","article-title":"Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus","volume":"65","author":"Lit","year":"2006","journal-title":"Ann. Rheumatic Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2217\/bmm-2018-0217","article-title":"Increased circulating interleukin-8 levels in systemic lupus erythematosus patients: A meta-analysis","volume":"12","author":"Mao","year":"2018","journal-title":"Biomarkers Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87031","article-title":"A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood","volume":"1","author":"Mazaleuskaya","year":"2016","journal-title":"JCI Insight"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"New Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00005-014-0270-5","article-title":"Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis","volume":"62","author":"Nielepkowicz-Go\u017adzi\u0144ska","year":"2014","journal-title":"Archivum Immunologiae Ther. Exp."},{"key":"B27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10067-017-3799-y","article-title":"Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis","volume":"37","author":"Peng","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40264-018-0651-5","article-title":"Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk","volume":"41","author":"Scott","year":"2018","journal-title":"Drug Safety"},{"key":"B31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbalip.2012.07.019","article-title":"Lysoglycerophospholipids in chronic inflammatory disorders: The PLA 2\/LPC and ATX\/LPA axes","volume":"1831","author":"Sevastou","year":"2013","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.4161\/epi.22446","article-title":"PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation","volume":"7","author":"Venza","year":"2012","journal-title":"Epigenetics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1177\/0961203316629556","article-title":"IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus","volume":"25","author":"Yoshio","year":"2016","journal-title":"Lupus"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cei.12319","article-title":"Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: A potential contributor to interstitial lung disease complications","volume":"177","author":"Zhang","year":"2014","journal-title":"Clin. Exp. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00613\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T01:39:23Z","timestamp":1588729163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00613\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":37,"alternative-id":["10.3389\/fphar.2020.00613"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00613","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2019.12.30.890715","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"article-number":"613"}}